The effect of phospholipase C on the responsiveness of cardiac receptors. II. The specificity of phospholipase C inhibition of receptor-mediated responses.
D000109:Acetylcholine / Q000494:pharmacology; D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D002118:Calcium / Q000502:physiology; D002642:Chick Embryo; D004347:Drug Interactions; D006321:Heart / Q000187:drug effects*; D006339:Heart Rate / Q000187:drug effects; D008563:Membrane Lipids / Q000378:metabolism; D008761:Methylhistamines / Q000494:pharmacology; D009200:Myocardial Contraction / Q000187:drug effects*; D010740:Phospholipases / Q000494:pharmacology*; D010743:Phospholipids / Q000378:metabolism; D011956:Receptors, Cell Surface / Q000187:drug effects*; D010738:Type C Phospholipases / Q000494:pharmacology*
D008563:Membrane Lipids; D008761:Methylhistamines; D010743:Phospholipids; D011956:Receptors, Cell Surface; D000804:Angiotensin II; C025566:4-methylhistamine; D010740:Phospholipases; D010738:Type C Phospholipases; D000109:Acetylcholine; D002118:Calcium